Vor Biopharma
Price & Volume
Stats
See moreOpen | $14.32 |
Previous Close | $14.33 |
Day Range | $13.69-$14.32 |
52W Range | $2.62-$65.80 |
Market Cap | $685.3M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$70.50 |
News
See moreYahoo Finance • 30 days ago
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 4 months ago
Vor Bio Appoints RA Capital’s Andrew Levin, M.D., Ph.D., and Forbion’s Wouter Joustra to Board of Directors
Yahoo Finance • 5 months ago
Vor Biopharma (VOR) Is Up 45.6% After Telitacicept Phase 3 Win And JPMorgan Nod Has The Bull Case Changed?
Yahoo Finance • 6 months ago
Vor Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update
About
CEO | Dr. Jean-Paul Kress M.D. |
CFO | Mr. Sandesh Mahatme L.L.M. |
Address | 500 Boylston Street, Boston, MA, United States, 02116 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 76 |